… , transgenic mouse lines were developed for biosensor expression in adult cardiac tissue/…
By overexpressing PDE2A3 and PDE4B3 in failing mouse hearts, we investigated the β-AR-…

… activity in cell has not been reproduced in the mouse infection models for many viruses. Also,
… One such probable vaccine in the clinical trial stage is the recombinant adenovirus vector …

… protein in the various ocular tissues from patients. However, … experimental or clinical data
in mouse and human models. … In fact, procured and distributed donors have decreased since …

… Armesilla, Cardiovascular Molecular Pharmacology/ Director of … delivery of cytokines using
plasmid vectors or adenovectors … ) mouse models, 4 weeks post vector delivery demonstrating …

… in mouse models, and the results of my experiments can be used to direct future work aimed
at … delivery methods to introduce a functional copy of a gene to a patient. A more recent …

… secreting tumors in a pre-clinical mouse model of prostate cancer (8,… Additional pre-clinical
pharmacology /toxicology studies … intra-tumoral delivery of an adenovirus vector harboring the …

… the appropriate distribution of Cx43 gap junctions at intercalated … An adenovirus vector with
genetically modified fibers … human adenoviral vectors in mouse heart tissue which may not …

… through genetic modification and delivery methods. Covalent conjugates, … delivery of
mRNA. Furthermore, mRNA vaccines can be administered repeatedly without any concern over …

… infiltrate the ocular tissues which will then quickly dissolve to distribute the drug to both …
response from antigen-specific antibody in a mouse model after 2 weeks of vaccination. The …